Assessment of the pharmacokinetics of Eltrombopag along with the effect of sex and genetic polymorphisms on its variability in healthy Chinese subjects
Latest Information Update: 05 Apr 2021
At a glance
- Drugs Eltrombopag (Primary)
- Indications Acute myeloid leukaemia; Aplastic anaemia; Idiopathic thrombocytopenic purpura; Radiation injuries; Thrombocytopenia; Transplant rejection
- Focus Pharmacokinetics
- 05 Apr 2021 New trial record
- 29 Mar 2021 Results published in the European Journal of Drug Metabolism and Pharmacokinetics